Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Stratec SE

Market Cap 221M 254M 204M 192M 359M 23.96B 362M 2.43B 943M 11.81B 954M 934M 40.92B P/E 2026 *
17.7x
P/E 2027 * 12.1x
Enterprise Value 322M 370M 297M 279M 522M 34.84B 526M 3.53B 1.37B 17.17B 1.39B 1.36B 59.51B EV / Sales 2026 *
1.21x
EV / Sales 2027 * 1.12x
Free-Float
49.38%
Yield 2026 *
3.68%
Yield 2027 * 4.24%
Manager TitleAgeSince
Chief Executive Officer 58 01/04/2011
Director of Finance/CFO 38 01/11/2025
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 29/05/2019
Chairman 68 20/05/2022
Director/Board Member 73 21/07/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 261M
+0.63%-2.32%+18.35%-11.91% 172B
+1.14%-1.48%-20.16%+24.08% 142B
-0.33%-2.00%-8.88%-25.12% 126B
+0.76%-3.99%-55.32%-16.19% 66.81B
+0.78%+1.87%+18.09%-4.95% 49.91B
-0.63%-1.91%-24.94%-34.79% 44.81B
+2.20%-1.92%+9.99%+7.53% 35.11B
-0.44%-1.20%+4.74%+35.01% 35.05B
+0.72%-4.53%-14.33%-21.94% 27.82B
Average +0.55%-3.15%-8.05%-5.36% 77.7B
Weighted average by Cap. +0.66%-3.30%-6.62%-5.40%

Financials

2026 *2027 *
Net sales 267M 307M 246M 232M 433M 28.89B 436M 2.93B 1.14B 14.24B 1.15B 1.13B 49.35B 284M 326M 262M 246M 460M 30.71B 464M 3.11B 1.21B 15.13B 1.22B 1.2B 52.45B
Net income 14.02M 16.09M 12.93M 12.16M 22.75M 1.52B 22.91M 154M 59.73M 747M 60.41M 59.11M 2.59B 18.29M 20.99M 16.86M 15.86M 29.66M 1.98B 29.87M 201M 77.88M 975M 78.77M 77.09M 3.38B
Net Debt 101M 115M 92.73M 87.22M 163M 10.88B 164M 1.1B 428M 5.36B 433M 424M 18.59B 97.7M 112M 90.06M 84.71M 158M 10.57B 160M 1.07B 416M 5.21B 421M 412M 18.05B
Logo Stratec SE
Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Employees
1,395
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
18.22EUR
Average target price
25.40EUR
Spread / Average Target
+39.41%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!